![]() ![]() No cash balance or cash flow is included in the calculation. Please note all regulatory considerations regarding the presentation of fees must be taken into account. Backtested results are adjusted to reflect the reinvestment of dividends and other income and, except where otherwise indicated, are presented gross-of fees and do not include the effect of backtested transaction costs, management fees, performance fees or expenses, if applicable. ![]() Actual performance may differ significantly from backtested performance. Further, backtesting allows the security selection methodology to be adjusted until past returns are maximized. Since trades have not actually been executed, results may have under- or over-compensated for the impact, if any, of certain market factors, such as lack of liquidity, and may not reflect the impact that certain economic or market factors may have had on the decision-making process. Specifically, backtested results do not reflect actual trading or the effect of material economic and market factors on the decision-making process. Backtested performance is developed with the benefit of hindsight and has inherent limitations. This information is provided for illustrative purposes only. No representations and warranties are made as to the reasonableness of the assumptions. Xos Inc Stock Forecast, Predictions & Price Target Overview Forecast Earnings Dividend Ownership Analyst price target for XOS All Analysts Top Analysts Based on 3 analyst s offering 12 month price targets for Xos Inc. Certain assumptions have been made for modeling purposes and are unlikely to be realized. Changes in these assumptions may have a material impact on the backtested returns presented. General assumptions include: XYZ firm would have been able to purchase the securities recommended by the model and the markets were sufficiently liquid to permit all trading. ![]() Backtested results are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. Backtested performance is not an indicator of future actual results. The company was incorporated in 2013 and is headquartered in Salt Lake City, Utah.Disclaimer: The TipRanks Smart Score performance is based on backtested results. In addition, it intends to sell diagnostic equipment from other manufacturers as self-contained lab systems. The company also provides tests that identify genetic traits in plant and animal genomes and portable PCR device designed to bring PCR to patients in point-of-care and at-home settings. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and C, human papilloma virus, malaria, chikungunya, dengue, and the zika virus three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos and molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications. Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |